Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
Lipodystrophies represent a therapeutic challenge with regards to insulin resistance,
hypertriglyceridemia and fatty liver which often is coupled with significant adipose tissue
loss. The purpose of the study is to examine the safety and efficacy of Leptin on subjects
with lipodystrophy.